BDX (bd.com) נכסים נקיים של החברה

This Becton Dickinson & Co (BDX) price chart illustrates the price action of the medical equipment manufacturer, whose value is currently 24.34. Becton Dickinson & Co is scaling its portfolio of intelligent drug delivery systems and laboratory analysis. Growth is driven by mergers and digital partnerships within the IT sector. Meanwhile, the business is countering pressure from tech startups and corporate behemoths in the competition for hospital contracts.

Becton Dickinson & Co (BDX) maintains its leadership in the medical consumables sector through systemic innovation. This indicator reflects the difference between total assets and liabilities, excluding market volatility. By analyzing the movement of the company's balance sheet capital, an investor assesses the real value of net assets. Effective M&A management by top executives directly impacts the growth of this fundamental base. A stable trend confirms the long-term resilience of the business.